Works by Gong-Yan Chen


Results: 10
    1
    2
    3
    4
    5
    6
    7
    8
    9

    A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 2, p. 477, doi. 10.1007/s10637-020-01010-4
    By:
    • Yang, Jin-Ji;
    • Fang, Jian;
    • Shu, Yong-Qian;
    • Chang, Jian-Hua;
    • Chen, Gong-Yan;
    • He, Jian Xing;
    • Li, Wei;
    • Liu, Xiao-Qing;
    • Yang, Nong;
    • Zhou, Caicun;
    • Huang, Jian An;
    • Frigault, Melanie M.;
    • Hartmaier, Ryan;
    • Ahmed, Ghada F.;
    • Egile, Coumaran;
    • Morgan, Shethah;
    • Verheijen, Remy B.;
    • Mellemgaard, Anders;
    • Yang, Liu;
    • Wu, Yi-Long
    Publication type:
    Article
    10

    Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 12, p. 10771, doi. 10.1007/s00432-023-04923-8
    By:
    • Zhou, Qing;
    • Zhang, He-Long;
    • Jiang, Li-Yan;
    • Shi, Yuan-Kai;
    • Chen, Yuan;
    • Yu, Jin-Ming;
    • Zhou, Cai-Cun;
    • He, Yong;
    • Hu, Yan-Ping;
    • Liang, Zong-An;
    • Pan, Yue-Yin;
    • Zhuo, Wen-Lei;
    • Song, Yong;
    • Wu, Gang;
    • Chen, Gong-Yan;
    • Lu, You;
    • Zhang, Cui-Ying;
    • Zhang, Yi-Ping;
    • Cheng, Ying;
    • Lu, Shun
    Publication type:
    Article